The Estimated Lifetime Quality-Adjusted Life-Years Lost Due to Chlamydia, Gonorrhea, and Trichomoniasis in the United States in 2018
- PMID: 36806950
- PMCID: PMC10112678
- DOI: 10.1093/infdis/jiad047
The Estimated Lifetime Quality-Adjusted Life-Years Lost Due to Chlamydia, Gonorrhea, and Trichomoniasis in the United States in 2018
Abstract
Background: Comprehensive evaluation of the quality-adjusted life-years (QALYs) lost attributable to chlamydia, gonorrhea, andtrichomoniasis in the United States is lacking.
Methods: We adapted a previous probability-tree model to estimate the average number of lifetime QALYs lost due to genital chlamydia, gonorrhea, and trichomoniasis, per incident infection and at the population level, by sex and age group. We conducted multivariate sensitivity analyses to address uncertainty around key parameter values.
Results: The estimated total discounted lifetime QALYs lost for men and women, respectively, due to infections acquired in 2018, were 1541 (95% uncertainty interval [UI], 186-6358) and 111 872 (95% UI, 29 777-267 404) for chlamydia, 989 (95% UI, 127-3720) and 12 112 (95% UI, 2 410-33 895) for gonorrhea, and 386 (95% UI, 30-1851) and 4576 (95% UI, 13-30 355) for trichomoniasis. Total QALYs lost were highest among women aged 15-24 years with chlamydia. QALYs lost estimates were highly sensitive to disutilities (health losses) of infections and sequelae, and to duration of infections and chronic sequelae for chlamydia and gonorrhea in women.
Conclusions: The 3 sexually transmitted infections cause substantial health losses in the United States, particularly gonorrhea and chlamydia among women. The estimates of lifetime QALYs lost per infection help to prioritize prevention policies and inform cost-effectiveness analyses of sexually transmitted infection interventions.
Keywords: burden of disease; chlamydia; gonorrhea; quality-adjusted life-years; sexually transmitted diseases; trichomoniasis.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. M.M.R. reports contract from World Health Organization, not related to the manuscript, and grant from Harvard University Center for AIDS Research Developmental Grant, not related to the manuscript. S.Y. reports doctoral stipend from New York University Grossman School of Medicine, not related to the manuscript. All other authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures






References
-
- Centers for Disease Control and Prevention . Sexually transmitted disease surveillance 2018. Atlanta: US Department of Health and Human Services, 2018.
-
- Centers for Disease Control and Prevention . About notifiable infectious diseases and conditions data, 21 October 2022. https://www.cdc.gov/nndss/data-statistics/infectious-tables/about.html. Accessed 9 January 2023.
-
- Centers for Disease Control and Prevention . Sexually transmitted disease surveillance 2016. Atlanta: US Department of Health and Human Services, 2017.
-
- Centers for Disease Control and Prevention . Tracking the hidden epidemics: trends in STDs in the United States 2000. Atlanta: US Department of Health and Human Services, 2001.
-
- Reekie J, Donovan B, Guy R, et al. . Risk of pelvic inflammatory disease in relation to chlamydia and gonorrhea testing, repeat testing, and positivity: a population-based cohort study. Clin Infect Dis 2018; 66:437–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical